Patient Derived Equipment
-
Manufactured by Khloris Biosciences, Inc.based in USA
By developing cardiomyocytes directly from patient-derived iPSCs, we create a non-invasive, personalized platform to directly observe the effects of drug therapies on heart ...
-
Manufactured by Regeneron Pharmaceuticals Inc.based in USA
VelociHum is our immunodeficient mouse platform that can be used to accurately test human therapeutics against human immune cells and to study human tumor models. Through genetic humanizations, VelociHum mice have been optimized to allow for better development of human immune cells in vivo, as well as to allow for engraftment of primary ...
-
Manufactured by GC Therapeutics Inc.based in USA
GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for ...
-
Manufactured by XILIS, Inc.based in USA
Xilis’ proprietary MicroOrganoSphere (MOS) technology represents a new standard in patient-derived micro-tumor production. From each patient, MOS retains unique patient tissue structure, genetic alterations, gene expression, immune microenvironment and histopathology. Overcoming major limitations of widely used, yet ...
-
Manufactured by Regenerative Medical Solutions Inc. (RMS)based in USA
We are developing autologous and allogeneic versions of ILC cellular therapeutic. In the case of autologous ILC cellular therapeutic we will convert the diabetes patients own cells into iPSC cells followed by differentiation of the patient derived iPSC into ILC using our patented and proprietary technology. These patient cell ...
-
Manufactured by SEngine Precision Medicinebased in USA
with our patient-derived 3D tumor organoids to identify translational biomarkers and develop new cancer-fighting drugs. ...
-
Manufactured by Cellesce Ltdbased in UNITED KINGDOM
Derived from patient tissue our colorectal cancer organoids are available from a range of sites and TNM stages. They cover varied morphologies and growth ...
-
Manufactured by Cellesce Ltdbased in UNITED KINGDOM
Organoids are derived from biopsies and tissues sampled from patients or subjects (usually termed Patient-Derived Organoids, or PDOs). PDOs are self-organising cell structures that mimic the tissue or organ from which they are derived – they are often termed ‘mini-organs’. ...
-
Manufactured by Editas Medicinebased in USA
EDIT-301 is an experimental cell therapy medicine under investigation for the treatment of severe sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). EDIT-301 consists of patient-derived CD34+ hematopoietic stem and progenitor cells edited at the gamma globin gene (HBG1 and HBG2) promoters, where naturally occurring ...
-
Manufactured by InSphero AGbased in SWITZERLAND
An in vitro PDX model with in vivo-like heterogeneity. 3D InSight™ Tumor Microtissues from Patient-Derived Xenografts (PDX) are custom assay-ready 3D in vitro tumor models engineered to reflect complex tumor biology without the use of artificial matrices. Ideal for early stage cancer drug efficacy testing and screening ...
-
Manufactured by Universal Cells Inc.based in USA
Realizing the potential of pluripotent stem cells requires that the therapeutic cells derived from PSCs be accepted by patients. PSC-derived cells that have not been engineered to avoid allogeneic rejection will be eliminated soon after transplantation unless they are HLA-matched to their recipients, delivered to immune privileged ...
-
Manufactured by CNSystems Medizintechnik GmbHbased in AUSTRIA
Task Force Touch CARDIO provides a set of synchronized patient signals derived from the unique non-invasive CNAP finger sensor, combined with wireless 12-channel ECG. It is patient-friendly, easy to use and supports you in your busy daily clinical routine when it matters ...
-
Manufactured by JW Holdingsbased in NORTH KOREA
DC vaccine derived from patient’s own blood cells is the personalized immunotherapeutic vaccine for cancer and auto-immune diseases. Disease specific antigens-loaded dendritic cell allows the immune cells to recognize and attack only cancer cells through a tumor specific antigen recognition ...
-
Manufactured by RTsafebased in GREECE
Encephalon 3D is a single-use head phantom constructed from bone equivalent material. The brain is filled with 3D polymer gel dosimeter, as a tissue equivalent material, giving to the end-user the ability to gain a real-3D map of the delivered ...
-
Manufactured by Boston Pharmaceuticalsbased in USA
BOS172738 is a highly selective, reversible, ATP-competitive RET (Rearranged during Transfection) kinase inhibitor. RET rearrangements and activating mutations are found in multiple solid tumors, but especially with non-small cell lung cancers and medullary thyroid carcinomas. ...
-
Manufactured by Rocket Pharmaceuticals, Inc.based in USA
FA is a rare, genetic disorder affecting DNA repair. Approximately two-thirds of FA cases are caused by genetic defects in the FANCA gene, which results in the FA subtype known as FA Complementation Group A (FA-A). FA patients may develop bone marrow failure (very low blood counts), cancers of the blood or other ...
-
Manufactured by Exscientiabased in UNITED KINGDOM
EXS21546 is our peripherally-restricted and selective antagonist of the Adenosine A2a Receptor. It is designed for anti-cancer immunotherapy, combatting adenosine related immunosuppressive effects, through T-cell ...
-
Manufactured by Rocket Pharmaceuticals, Inc.based in USA
LAD-I is a rare genetic disorder affecting the immune system and is caused by a defect in the ITGB2 gene, leading to a deficiency in CD18. Due to this deficiency, white blood cells (primarily neutrophils) are unable to leave the bloodstream to go to the site of infection. As a result, patients with severe LAD-I can develop ...
-
Manufactured by Rocket Pharmaceuticals, Inc.based in USA
PKD is a rare, genetic blood disorder. PKD is caused by a defect in the PKLR gene which is responsible for energy production in red blood cells (RBCs). RBCs carry oxygen to the rest of the body. When the PKLR gene has a defect, RBCs are limited in their ability to produce energy and remain intact. As a result, patients with PKD frequently ...
-
Manufactured by Benevolentbased in UNITED KINGDOM
work on all patients. Our work focuses on developing safer and more effective oral small molecule treatments. Progress so far: For our most advanced UC programme, we identified an AI-generated target with novel mechanisms of action in UC, and rapidly delivered a candidate drug to IND/CTA-enabling ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you